Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries

被引:40
作者
Hoefeler, H. [1 ]
Duran, I. [2 ,3 ]
Hechmati, G. [4 ]
Garzon Rodriguez, C. [5 ]
Lueftner, D. [6 ]
Ashcroft, J. [7 ]
Bahl, A. [8 ]
Atchison, C. [9 ]
Wei, R. [10 ]
Thomas, E. [11 ]
Lorusso, V. [12 ,13 ]
机构
[1] Forschungsszentrum Ruhr, KliFoCtr GmbH, D-58455 Witten, Germany
[2] Hosp Univ Virgen del Rocio, Seville 41013, Spain
[3] Ctr Integral Oncol Clara Campal, Madrid 28050, Spain
[4] Amgen Europe GmbH, CH-6301 Zug, Switzerland
[5] Inst Catala Oncol, Barcelona 08908, Spain
[6] Univ Med Berlin, D-10117 Berlin, Germany
[7] Mid Yorkshire Hosp NHS Trust, Pinderfields Hosp, Wakefield WF1 4DG, Yorks, England
[8] Univ Hosp Bristol, Bristol Haematol & Oncol Ctr, Bristol BS2 8ED, Avon, England
[9] Amgen Inc, Hlth Econ, Thousand Oaks, CA 91320 USA
[10] Amgen Inc, Biostatistics, Newbury Pk, CA 91320 USA
[11] Amgen Europe GmbH, Sci Affairs, CH-6301 Zug, Switzerland
[12] ASL, Inst Oncol, I-73100 Lecce, Italy
[13] Ist Oncol Giovanni Paolo II, Natl Canc Inst, I-70124 Bari, Italy
关键词
Advanced cancer; Bone metastases; Health resource utilization; Observational research; Skeletal-related event; US MEDICARE BENEFICIARIES; POPULATION-BASED ANALYSIS; PROSTATE-CANCER; LUNG-CANCER; INCREASED SURVIVAL; BREAST-CANCER; COST; DISEASE; ABIRATERONE;
D O I
10.1016/j.jbo.2014.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Skeletal-related events (SREs; pathologic fracture, radiation or surgery to bone, spinal cord compression) frequently occur in patients with advanced cancer with bone metastases/lesions. Limited data on the associated patient and economic burden are available to aid in resource planning and evaluating treatment options. Methods: Patients with bone metastases/lesions secondary to breast, lung or prostate cancer or multiple myeloma; with at least one SRE within 97 days prior to enrollment; life expectancy of at least 6 months; and Eastern Cooperative Oncology Group performance status 0, 1 or 2 were recruited. Information on health resource utilization (HRU; including number/duration of hospitalizations, outpatient visits, procedures), attributed by investigators to be associated with a SRE, was collected retrospectively for up to 97 days prior to enrollment and prospectively for up to 18-21 months. Results: A total of 631 patients contributing 1282 SREs, were enrolled across Germany, Italy, Spain and the United Kingdom. Approximately a third of all SREs required an inpatient stay. Mean duration of inpatient stay for patients with SREs requiring one ranged from 8.4 to 41.1 days across all countries and SRE types. Conclusion: All types of SREs are associated with substantial HRU burden. Preventing SREs by using the best therapeutic options available may help to reduce the burden to patients and healthcare systems. (C) 2014 Published by Elsevier GmbH.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 24 条
[1]  
[Anonymous], 2013, GLOBOCAN 2012 V1 0 C
[2]   The incidence and prognostic significance of bone metastases and skeletal-related events in lung cancer patients: A population-based cohort study in Denmark. [J].
Chia, V. M. ;
Cetin, K. ;
Jacobsen, J. B. ;
Norgaard, M. ;
Jensen, A. O. ;
Christiansen, C. F. ;
Sorensen, H. T. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[3]   Clinical features of metastatic bone disease and risk of skeletal morbidity [J].
Coleman, Robert E. .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6243S-6249S
[4]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[5]   Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer A French Prospective, Observational, Multicenter Study (GFPC 0601) [J].
Decroisette, Chantal ;
Monnet, Isabelle ;
Berard, Henri ;
Quere, Gilles ;
Le Caer, Herve ;
Bota, Suzanna ;
Audigier-Valette, Clarisse ;
Geriniere, Laurence ;
Vernejoux, Jean-Marc ;
Chouaid, Christos .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :576-582
[6]   The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer [J].
Delea, T ;
Langer, C ;
McKiernan, J ;
Liss, M ;
Edelsberg, J ;
Brandman, J ;
Sung, J ;
Raut, M ;
Oster, G .
ONCOLOGY, 2004, 67 (5-6) :390-396
[7]  
Delea Thomas, 2006, J Support Oncol, V4, P341
[8]  
European Medicines Agency, 2012, DEN XGEVA SUMM PROD
[9]   Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System [J].
Felix, J. ;
Andreozzi, V. ;
Soares, M. ;
Borrego, P. ;
Gervasio, H. ;
Moreira, A. ;
Costa, L. ;
Marcelo, F. ;
Peralta, F. ;
Furtado, I. ;
Pina, F. ;
Albuquerque, C. ;
Santos, A. ;
Passos-Coelho, J. L. .
VALUE IN HEALTH, 2011, 14 (04) :499-505
[10]  
Hechmati G, 2013, J Med Econ, V16, P691, DOI 10.3111/13696998.2013.779921